Page last updated: 2024-08-21

isoxazoles and cep-32496

isoxazoles has been researched along with cep-32496 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, S; Apuy, JL; Armstrong, RC; Ator, MA; Bhagwat, S; Campbell, BT; Chao, Q; Cramer, MD; Dorsey, BD; Ezawa, M; Faraoni, R; Gardner, MF; Ghose, AK; Gibney, M; Gitnick, D; Gunawardane, RN; Herbertz, T; Holladay, MW; Hua, H; Insko, DE; James, J; Jones-Bolin, S; Lai, AG; Nepomuceno, RR; Rowbottom, MW; Ruggeri, B; Setti, E; Sprankle, KG; Struss, B; Tran, L; Valenta, I; Williams, M1

Other Studies

1 other study(ies) available for isoxazoles and cep-32496

ArticleYear
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (B
    Journal of medicinal chemistry, 2012, Feb-09, Volume: 55, Issue:3

    Topics: Administration, Oral; Animals; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Dogs; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles; Macaca fascicularis; Male; Mice; Mice, Nude; Microsomes, Liver; Models, Molecular; Mutation; Neoplasm Transplantation; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Quinazolines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous

2012